Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Contact and Intraocular Lenses Companies

Contact and intraocular lenses companies specialize in the development and manufacturing of lenses used for vision correction, including contact lenses for external wear and intraocular lenses for surgical implantation. These companies play a crucial role in providing solutions for various vision-related conditions.

Contact and Intraocular Lenses Key CompaniesDisclaimer: List of key companies in no particular orderLatest Contact and intraocular lenses Companies Update



  • June 2023: Interim results from a trial conducted by MediPrint Ophthalmics have shown that the company's drug-releasing contact lens can successfully lower intraocular pressure (IOP) in glaucoma patients. When it comes to MediPrint's contact lens-based ocular medication delivery portfolio, LL-BMT1 is the crown jewel. The mission of the California, US-based firm is to provide choices for treating eye disorders and ailments in patients so that they can keep using contact lenses to correct their vision. The SIGHT (Sustained Innovative Glaucoma and Ocular Hypertension Treatment) trial programme includes the Phase IIb study. The purpose of SIGHT-2 is to determine the optimal dosing schedule for LL-BMT1, a weekly medicated contact lens that releases bimatoprost without the use of preservatives. Ocular hypertension can be managed with the use of the eye drop bimatoprost.




  • January 2023: The partnership between Boomerang Ventures Studio, Purdue Foundry, and the Purdue Research Foundation Office of Technology Commercialization will result in the formation of BVS Sight Inc. in January 2023. The collaboration advances pre-market health care intellectual property and Purdue-related health care businesses. A new company will bring smart contact lenses created at Purdue University to market, giving optometrists, ophthalmologists, and their patients access to cutting-edge technology for early glaucoma detection. Patients with increased IOP variability may be at a higher risk for glaucoma development, since studies have linked IOP variability to the destruction of retinal structures in glaucoma patients. The lens power, biocompatibility, softness, transparency, wettability, oxygen transmissibility, and overnight wearability of smart soft contact lenses are all maintained.


List of Contact and intraocular lenses Key companies in the market

  • Johnson & Johnson Services, Inc. (US)

  • Bausch & Lomb Incorporated (US)

  • Alcon (Switzerland)

  • Hoya Corporation (Japan)

  • Carl Zeiss Meditec AG (Germany)

  • Staar Surgical (US)

  • HumanOptics AG (Germany)

  • Nidek Co., Ltd. (Japan)

  • Physiol (Belgium)

  • The Cooper Companies, Inc. (US)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.